In this article by Nigel Rawson and John Adams for the Macdonald-Laurier Institute, they explore how Canada’s slow approval and reimbursement systems delay patient access to new medicines for years. The authors warn that these delays leave patients waiting for treatments available elsewhere. They call for faster, coordinated processes and modernized reviews. The piece urges action so Canadians can get life-saving care sooner and avoid preventable suffering